Abstract
Tivozanib (Fotivda (R)) is an oral, potent and highly selective vascular endothelial growth factor receptor (VEGFR) inhibitor that has been approved i......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
